Susquehanna International Group, LLP Kiora Pharmaceuticals Inc Call Options Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
About KIORA PHARMACEUTICALS INC
- Ticker KPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 919,078
- Market Cap $3.43M
- Description
- Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...